By stimulating the body’s natural defenses to fight cancer, the technique of immunotherapy upset the approach of cancer treatments. Today, it is patients with Parkinson disease who are looking at these new techniques with hope.
In the columns of the Parisian, Professor Philippe Damier, neurologist at Nantes hospital has just announced that immunotherapy treatment trials were currently underway on patients affected by Parkinson’s disease.
What will the treatment do?
In cancer, treatment helps the patient defend themselves against tumors by injecting specific antibodies. In Parkinson’s disease, the antibodies will target protein deposits in brain cells in order to destroy them.
The goal is to slow down the degenerative process, even to stop it if it happens at the very beginning of the disease.
“We are starting phase II of the international clinical study with patients infused every month”, reveals Philippe Damier.
Read also :
The intestine would also play a role in Parkinson’s disease
Parkinson’s: a new warning sign to watch closely
